Cardiac resynchronisation therapy and the role of optimal device utilisation.
Despite established selection criteria, 30 to 40% of patients do not respond to cardiac resynchronisation therapy. By optimising programming of the device response to cardiac resynchronisation, therapy can be improved. (Neth Heart J 2009;17:354-7.).
Buck
S
S
Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Maass
A H
AH
van Veldhuisen
D J
DJ
Van Gelder
I C
IC